Rump A F, Rösen R, Korth A, Klaus W
Institut für Pharmakologie, Universität Köln, Germany.
Eur Heart J. 1993 Jan;14(1):106-12. doi: 10.1093/eurheartj/14.1.106.
The endogenous activity of the local renin-angiotensin system (RAS) and the anti-ischaemic properties of captopril were investigated in electrically driven rabbit Langendorff hearts (constant pressure: 70 cmH2O, Tyrode solution, Ca2+ 1.8 mmol.l-1). Cumulative concentration-response curves showed no significant difference (P > 0.05) between the reduction of the global coronary flow (CF) by exogenous angiotensin-I or angiotensin-II (EC50 = 10(-10) mol.l-1). It is concluded that the local RAS in isolated rabbit hearts is highly sensitive, whereas its endogenous activity is very low due to very low endogenous angiotensin-I content. Myocardial ischaemia (MI) was induced by the occlusion of a left coronary artery branch and MI was quantified from NADH surface fluorescence photography. MI was significantly enlarged (+35%) (P < 0.05) by exogenous angiotensin-I (6 x 10(-9) mol.l-1). The reduction in CF and the increment in MI by angiotensin-I could be completely prevented by adding captopril at a low concentration (10(-6) mol.l-1) to the perfusion buffer. In the absence of exogenous angiotensin-I, captopril alone (10(-6) mol.l-1) neither significantly enhanced CF (P > 0.05), nor diminished MI (P > 0.05), supporting the finding of very low endogenous activity of the local RAS in this model. We, moreover, conclude that at a low concentration (10(-6) mol.l-1) captopril does not possess direct cardioprotective properties independent of its ACE inhibiting action.
在电驱动的兔Langendorff心脏(恒压:70 cmH₂O,台氏液,Ca²⁺ 1.8 mmol·L⁻¹)中研究了局部肾素-血管紧张素系统(RAS)的内源性活性以及卡托普利的抗缺血特性。累积浓度-反应曲线显示,外源性血管紧张素-I或血管紧张素-II对整体冠状动脉血流量(CF)的降低作用之间无显著差异(P>0.05)(EC₅₀ = 10⁻¹⁰ mol·L⁻¹)。得出的结论是,离体兔心脏中的局部RAS高度敏感,但其内源性活性非常低,原因是内源性血管紧张素-I含量极低。通过结扎左冠状动脉分支诱导心肌缺血(MI),并通过NADH表面荧光摄影对MI进行定量。外源性血管紧张素-I(6×10⁻⁹ mol·L⁻¹)可使MI显著扩大(+35%)(P<0.05)。在灌注缓冲液中加入低浓度(10⁻⁶ mol·L⁻¹)的卡托普利可完全防止血管紧张素-I引起的CF降低和MI增加。在没有外源性血管紧张素-I的情况下,单独使用卡托普利(10⁻⁶ mol·L⁻¹)既不会显著增加CF(P>0.05),也不会减少MI(P>0.05),这支持了该模型中局部RAS内源性活性非常低的发现。此外,我们得出结论,低浓度(10⁻⁶ mol·L⁻¹)的卡托普利不具有独立于其ACE抑制作用的直接心脏保护特性。